These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Results of adjuvant BCG immunotherapy in malignant melanoma.
    Author: Wätzig V, Knopf B.
    Journal: Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442.
    Abstract:
    98 stage I melanoma patients and 16 stage II melanoma patients were included in this BCG immunotherapy trial. The postoperative treatment was performed by a high dose of BCG (Jena strain) administered by scarification with an intensive schedule. Compared to a similar historical control group treated by surgery alone (69 cases), the stage I melanoma patients showed a significantly improved recurrence rate and survival rate. In stage II melanoma patients we cannot prove any therapeutical effect of BCG therapy.
    [Abstract] [Full Text] [Related] [New Search]